Goldman Sachs · REGN Holdings Trend
Regeneron Pharmaceuticals · SEC 13F
Goldman Sachs Holdings of REGN by Quarter
Quarter Shares Value
| Quarter | Shares | Value | QoQ Change |
|---|---|---|---|
| 2024Q1 | 3.9M | $2.5B | — |
| 2024Q2 | 689K | $724M | -70.7% |
| 2024Q3 | 609K | $640M | -11.5% |
| 2024Q4 | 645K | $459M | -28.3% |
| 2025Q1 | 2.0M | $1.3B | +173.5% |
| 2025Q2 | 1.6M | $949M | -24.4% |
| 2025Q3 | 953K | $536M | -43.5% |
| 2025Q4 | 1.1M | $847M | +58.1% |
| 2026Q1 | 2.4M | $1.9B | +118.7% |
← Back to REGN holders ← Back to REGN profile
Data source: SEC EDGAR Form 13F